茂田 浩平

Medicine & Life Sciences

1. Colorectal Neoplasms 100%
2. Neoplasm Metastasis 32%
3. Laparoscopy 30%
4. Colorectal Surgery 27%
5. Neoplasms 24%
6. Rectal Neoplasms 20%
7. Hepatocellular Carcinoma 20%
8. Recurrence 17%
9. Survival 17%
10. Lymph Nodes 15%
11. Fluorouracil 14%
12. Meta-Analysis 14%
13. Pouchitis 14%
14. Ulcerative Colitis 14%
15. Postoperative Complications 14%
16. HSP27 Heat-Shock Proteins 14%
17. Anastomotic Leak 14%
18. Colonic Neoplasms 13%
19. Death Domain Receptors 11%
20. Liver 11%
21. T-Lymphocytes 11%
22. regorafenib 10%
23. Elderly 10%
24. Metformin 10%
25. Drug Therapy 10%
26. apatorsen 10%
27. Surgical Wound Infection 10%
28. Liver Neoplasms 9%
29. STX-0119 9%
30. Restorative Proctocolectomy 8%
31. Leucovorin 8%
32. Drainage 8%
33. Blood Vessels 8%
34. Tegafur 8%
35. Surgical Gloves 7%
36. Irinotecan 7%
37. Duodenal Neoplasms 7%
38. Adjuvant Chemotherapy 7%
39. Sorafenib 7%
40. Systematic Reviews 7%
41. Uracil 7%
42. Angiopoietins 7%
43. Hypocapnia 7%
44. Ehlers-Danlos Syndrome 6%
45. Obesity 6%
46. Colectomy 6%
47. Bevacizumab 6%
48. Deep Learning 6%
49. Therapeutics 6%
50. Confidence Intervals 6%